Capecitabine Maintenance in Metastatic Nasopharyngeal Carcinoma

被引：0
|
作者：
Ganguly, Shuvadeep [1 ]
Gogia, Ajay [1 ]
机构：
[1] All India Inst Med Sci, Dr BRA Inst Rotary Canc Hosp, Dept Med Oncol, New Delhi, India
来源：
JAMA ONCOLOGY | 2022年 / 8卷 / 08期
关键词：
D O I：
10.1001/jamaoncol.2022.2062
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1223 / 1224
页数：2
相关论文
共 50 条
  • [31] Use of capecitabine in refractory metastatic medullary thyroid carcinoma
    Eduardo Paiva, Carlos
    Carlito Michelin, Odair
    THYROID, 2008, 18 (05) : 587 - 587
  • [32] The efficacy and safety of apatinib plus capecitabine in platinum-refractory metastatic and/or recurrent nasopharyngeal carcinoma: a prospective, phase II trial
    Tang, Lin-Quan
    Li, Xiao-Yun
    Li, Zhi-Ming
    Liu, Zhi-Gang
    Lin, Miao-Zhen
    Zhou, Huan
    Yu, Qi-Wen
    Zhou, Jian
    Zhao, Chong
    Chen, Ze-Bin
    Wang, Xi-Cheng
    Peng, Jia-Yu
    Chen, Qiu-Yan
    Fang, Wen-Feng
    Yang, Yun-Peng
    Zhang, Bei
    Xia, Liang-Ping
    Hu, Pi-Li
    Hu, Wei-Han
    Li, Yi-Jie
    Mai, Hai-Qiang
    Cai, Xiu-Yu
    BMC MEDICINE, 2023, 21 (01)
  • [33] ACUTE APPENDICITIS SECONDARY TO METASTATIC NASOPHARYNGEAL CARCINOMA
    HSU, KL
    WANG, KS
    CHEN, L
    CHOU, FF
    JOURNAL OF SURGICAL ONCOLOGY, 1995, 60 (02) : 131 - 132
  • [34] The efficacy and safety of apatinib plus capecitabine in platinum-refractory metastatic and/or recurrent nasopharyngeal carcinoma: a prospective, phase II trial
    Lin-Quan Tang
    Xiao-Yun Li
    Zhi-Ming Li
    Zhi-Gang Liu
    Miao-Zhen Lin
    Huan Zhou
    Qi-Wen Yu
    Jian Zhou
    Chong Zhao
    Ze-Bin Chen
    Xi-Cheng Wang
    Jia-Yu Peng
    Qiu-Yan Chen
    Wen-Feng Fang
    Yun-Peng Yang
    Bei Zhang
    Liang-Ping Xia
    Pi-Li Hu
    Wei-Han Hu
    Yi-Jie Li
    Hai-Qiang Mai
    Xiu-Yu Cai
    BMC Medicine, 21
  • [35] Oral Capecitabine Achieves Response in Metastatic Eccrine Carcinoma
    Larson, Kristian
    Babiker, Hani M.
    Kovoor, Andrew
    Liau, Joy
    Eldersveld, Jordan
    Elquza, Emad
    CASE REPORTS IN ONCOLOGICAL MEDICINE, 2018, 2018
  • [36] Gemcitabine in metastatic nasopharyngeal carcinoma of the undifferentiated type
    Foo, KF
    Tan, EH
    Leong, SS
    Wee, JTS
    Tan, T
    Fong, KW
    Koh, L
    Tai, BC
    Lian, LG
    Machin, D
    ANNALS OF ONCOLOGY, 2002, 13 (01) : 150 - 156
  • [37] NASOPHARYNGEAL CARCINOMA METASTATIC TO THE CAUDA-EQUINA
    SIMPSON, RK
    GOODMAN, JC
    EHNI, G
    SURGICAL NEUROLOGY, 1986, 26 (03): : 306 - 310
  • [38] Efficacy and safety of apatinib combined with capecitabine in patients with advanced nasopharyngeal carcinoma
    Cai, X.
    Li, Z.
    Mai, H.
    Chen, Q.
    Zhao, C.
    ANNALS OF ONCOLOGY, 2020, 31 : S672 - S672
  • [39] COMBINED CHEMOTHERAPY FOR RECURRENT AND METASTATIC NASOPHARYNGEAL CARCINOMA
    AIROLDI, M
    PEDANI, F
    GABRIELE, P
    GIORDANO, C
    CAVALOT, A
    BRANDO, V
    JOURNAL OF CHEMOTHERAPY, 1989, 1 (04) : 272 - 276
  • [40] Diabetes as a Predictor of Survival in Metastatic Nasopharyngeal Carcinoma
    Ye, Xiao
    Jin, Ying
    Xing, Yubo
    Song, Yingxiang
    Wang, Lijun
    Su, Lizhong
    Zhang, Yiping
    Hua, Yanyin
    DIABETES, 2013, 62 : A405 - A406
12345